期刊文献+

牦牛乳酪蛋白肽分离组分对DPP-4活性的抑制作用 被引量:3

Dipeptidyl peptidase-4 inhibitory activity of fractions obtained from yak milk casein-derived peptides
原文传递
导出
摘要 以牦牛乳酪蛋白为原料,研究牦牛乳酪蛋白水解产物及其分离组分对二肽基肽酶-4(DPP-4)活性的抑制作用。以木瓜蛋白酶水解牦牛乳酪蛋白,水解产物采用Sephadex G-25凝胶过滤色谱进行分离,以DPP-4抑制率为指标,分析水解产物和分离组分对DPP-4活性的抑制作用。结果表明,木瓜蛋白酶水解0.5 h获得的水解产物表现出最强的DPP-4抑制活性,抑制率可达(59.57±0.23)%,半抑制浓度(IC50)为0.67 mg/m L。经Sephadex G-25凝胶过滤分离将木瓜蛋白酶水解产物分成4个组分,其中第3个组分对DPP-4抑制作用最强,IC50值为0.583 mg/m L。研究结果表明,与牦牛乳酪蛋白相比,其水解产物的DPP-4抑制活性显著增强,经凝胶过滤色谱分离后的水解产物分离组分具有更强的DPP-4抑制活性。 The dipeptidyl peptidase-4 (DPP-4) inhibitory activity of hydrolysates and fractions derived from yak milk casein were investigated. Yak milk casein was hydrolyzed by papain and the obtained hydrolysates were separated with gel filtration chromatography on Sephadex G-25. The DPP-4 inhibition rate of hydrolysates and fractions was determined. Results showed that papain hydrolysate obtained at 0.5 h hydrolysis exhibited the highest inhibitory activity against DPP-4 [(53.95±1.57)% inhibition]. IC50 value of 0.67 mg/mL was obtained for the hydrolysate. The hydrolysate was fractionated into 4 fractions by gel filtration chromatography on Sephadex G-25 and fraction 3 showed the highest DPP-4 inhibitory activity with IC50 value of 0.583 mg/mL. The results suggest that hydrolyzed yak milk casein possesses potent DPP-4 inhibitory activity compared with yak milk casein and hydrolysates fractionated by gel filtration chromatography showed higher inhibitory activity on DPP-4.
出处 《食品科技》 CAS 北大核心 2015年第8期16-20,共5页 Food Science and Technology
基金 国家级大学生科研创新项目(201410019040) 公益性行业(农业)科研专项(201303085) 国家自然科学基金面上项目(31371753)
关键词 牦牛乳 酪蛋白 水解产物 DPP-4抑制活性 yak milk casein hydrolysate dipeptidyl peptidase-4 inhibitory activity
  • 相关文献

参考文献19

  • 1DESHPANDE AD, HARRIS-HAYES M, SCHOOTMAN M. Epidemiology of diabetes and diabetes-relatedcomplications Physical Therapy,2008,88(11):1254-1264.
  • 2JATAV RK, KUMBHARE MB, CHENNAMANENI R.Cutaneous Manifestations of Diabetes Mellitus in Adult Patients of Telangana Region of South India[J]. European Journal of Academic Essays,2014,5(1):38-44.
  • 3VERSPOHL EJ. Novel pharmacological approaches to the treatment of type 2 diabetes[J]. Pharmacological Reviews,2012,64(2):188-237.
  • 4NONGONIERMA AB, FITZGERALD RJ. Utilisation of the isobole methodology to study dietary peptide-drug and peptide-peptide interactive effects on dipeptidyl peptidase IV (DPP—IV) inhibition[J]. Food & Function,2015,6(1):312-319.
  • 5NONGONIERMA AB, MOONEY C,SHIELDS DC, et al. In silico approaches to predict the potential of milk protein-derived peptides as dipeptidyl peptidase IV (DPP-IY) inhibitors[J]. Peptides,2014,57:43-51.
  • 6POWER O, NONGONIERMA AB, JAKEMAN P, et al. Food protein hydrolysates as a source of dipeptidyl peptidase IV inhibitory peptides for the management of type 2 diabetes[J]. Proceedings of the Nutrition Society ,2014,73(01):34-46.
  • 7KUSHNER P,GORRELL M. DPP-4 inhibitors in type 2 diabetes: Importance of selective enzyme inhibition and implications for clinical use[J]. The Journal of Family Practice,2010,59(2):1.
  • 8LI-CHAN ECY, HUNAG SL, JAO CL, et al. Peptides derived from atlantic salmon skin gelatin as dipeptidyl-peptidase IV inhibitors[J]. Journal of Agricultural and Food Chemistry,2012,60(4):973-978.
  • 9VELARDE-SALCEDO AJ, BARRERA-PACHECO A, LARA-GONZALEZ S, et al. In vitro inhibition of dipeptidyl peptidase IV by peptides derived from the hydrolysis of amaranth (Amaranthus hypochondriacus L.) proteins[J]. Food Chemistry,2013,136(2):758-764.
  • 10NONGONIERMA AB, FITZGERALD RJ. Dipeptidyl peptidase IV inhibitory and antioxidative properties of milk protein-derived dipeptides and hydrolysates[J],Peptides,2013,39:157-163.

二级参考文献20

  • 1DESHPANDE A D,HARRIS-HAYES M,SCHOOTMAN M.Epidemiology of diabetes and diabetes-related complications[J].Physical Therapy,2008,88(11):1254-1264.
  • 2DRUCKER D J.The biology of incretin hormones[J].Cell Metab,2006,3(3):153-165.
  • 3TULIPANO G,SIBILIA V,CAROLI A M,et al.Whey proteins as source of dipeptidyl dipeptidaseⅣ(dipeptidyl peptidase-4)inhibitors[J].Peptides,2011,32(4):835-838.
  • 4HATANAKA T,INOUE Y,ARIMA J,et al.Production of dipeptidyl peptidaseⅣinhibitory peptides from defatted rice bran[J].Food Chemistry,2012,134(2):797-802.
  • 5LI C J,LIU X J,BAI L,et al.Efficacy and safety of Vildagliptin,Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral hypoglycemic agents[J].Diabetology&Metabolic Syndrome,2014,6(1):69.
  • 6MAO X Y,CHENG X,WANG X,et al.Free-radical-scavenging and anti-inflammatory effect of yak milk casein before and after enzymatic hydrolysis[J].Food Chemistry,2011,126(2):484-490.
  • 7MAO X Y,NI J R,SUN W L,et al.Value-added utilization of yak milk casein for the production of angiotensin-Ⅰ-converting enzyme inhibitory peptides[J].Food Chemistry,2007,103(4):1282-1287.
  • 8WANG X,ZHOU J,TONG P S,et al.Zinc-binding capacity of yak casein hydrolysate and the zinc-releasing characteristics of casein hydrolysate-zinc complexes[J].Journal of Dairy Science,2011,94(6):2731-2740.
  • 9CHENG X,TANG X,WANG Q,et al.Antibacterial effect and hydrophobicity of yakκ-casein hydrolysate and its fractions[J].International Dairy Journal,2013,31(2):111-116.
  • 10NONGONIERMA A B,FITZGERALD R J.Susceptibility of milk protein-derived peptides to dipeptidyl peptidaseⅣ(DPP-Ⅳ)hydrolysis[J].Food Chemistry,2014,145:845-852.

共引文献2

同被引文献17

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部